Chemotherapy alters immune cell landscape in pancreatic cancer
Chemotherapy affects the ability of a patient's immune system to attack pancreatic tumors, a new study shows.
Mar 1, 2023
0
43
Chemotherapy affects the ability of a patient's immune system to attack pancreatic tumors, a new study shows.
Mar 1, 2023
0
43
Findings from the Garvan Institute of Medical Research reveal a new Australian drug that targets scar-like 'fibrotic' tissue within tumors shows promise for treating pancreatic ductal adenocarcinoma, one of the most aggressive ...
Aug 29, 2023
0
32
(HealthDay)—A model using routine clinical information can predict pancreatic ductal adenocarcinoma (PDA) following diagnosis of impaired fasting glucose (IFG), according to a study published in the January issue of the ...
Feb 14, 2022
0
20
Pancreatic cancers are among the most aggressive, deadly tumor types, and for years, researchers have struggled to develop effective drugs against the tumors. Now, Salk Institute researchers have identified a new set of molecules ...
Sep 6, 2023
1
53
Pancreatic cancer is not just one disease, but that's the way it is currently treated. New work from Tannishtha Reya's lab could help pave the way for a change. The research is published in the journal Cancer Cell.
Nov 6, 2023
0
27
A new approach to 'prime' the tumor environment may improve how effective chemotherapy is for pancreatic ductal adenocarcinoma, one of the most aggressive forms of pancreatic cancer.
Sep 29, 2021
0
64
A type of cell that plays a key role in pancreatic cancer can trace its origin back to a structure that forms during embryonic development, new research at MUSC Hollings Cancer Center shows. This new data, published recently ...
Jan 20, 2023
0
68
Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95 percent of pancreatic cancer cases. This fast-growing, often ...
Jan 3, 2013
0
0
A team based at North Carolina Central University (NCCU) and UNC Lineberger Comprehensive Cancer Center has established a connection between a known cancer gene called KRAS and a protein called Pim-1 kinase.
May 11, 2011
0
0
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths in the world. Mostly chemoresistant, PDAC so far has no effective treatment. Understanding the connective tissue, called stroma, ...
Jun 13, 2019
0
13